The EMRA offices will be closed for the upcoming holidays from Tuesday, December 24, 2024 thru Wednesday, January 1, 2025. We apologize for the inconvenience.
A new study evaluates whether administering 4-Factor Prothrombin Concentrate (4F-PCC) to patients at risk of massive transfusion due to trauma reduces the amount of blood products consumed.
The CAPE-COD Trial indicates it might be worth your time to consider hydrocortisone in managing community-acquired pneumonia in admitted patients boarding in the emergency department.
The use of extracorporeal membrane oxygenation - ECMO - as an adjunct to CPR following out-of-hospital cardiac arrest has gained a lot of attention. The INCEPTION Trial takes a closer look at the evid
The CLOVERS trial underscores the fact that fluid resuscitation strategies remain a highly debated and complex topic. It is still possible that specific patients may benefit from a restrictive fluid
Sepsis identification tools have many criticisms and vulnerabilities. The value of different sepsis care pathways has been a major area of research and discussion among clinicians. This has caused lar
Pelvic sepsis is a well-known and feared complication of colorectal and urologic surgery; however, it is not common and may not be recognized by emergency physicians. Patients may present with only mi
The bag-valve-mask (BVM) is ubiquitous and highly utilized in all fields of emergency care. Yet despite its seemingly intuitive operation and perceived simplicity, the BVM is an overlooked and misunde
Spontaneous (non-traumatic) intracerebral hemorrhage (ICH) is associated with high patient morbidity and mortality. In this Critical Care Alert, we review a study designed to assess whether prophylact
Alternative defibrillation techniques might be worth a second look. In this Critical Care Alert, we evaluate the largest and most rigorous study of double sequential external defibrillation (DSED) and